|
🐜
|
COVID‐19 Vaccine Response in People with Multiple Sclerosis
27 auth.
E. Tallantyre,
N. Vickaryous,
V. Anderson,
A. N. Asardag,
Dylan K. Baker,
J. Bestwick,
K. Bramhall,
R. Chance,
N. Evangelou,
K. George,
G. Giovannoni,
L. Grant,
K. Harding,
A. Hibbert,
G. Ingram,
...
M. Jones,
A. Kang,
S. Loveless,
S. Moat,
N. Robertson,
K. Schmierer,
S. Shah,
J. Simmons,
M. Upcott,
M. Willis,
S. Jolles,
R. Dobson
|
7 |
2021 |
7
🐜
|
|
🦁
|
Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis
7 auth.
N. Robertson,
J. O'Riordan,
J. Chataway,
D. Kingsley,
D. Miller,
D. Clayton,
...
D. Compston
|
6 |
1997 |
6
🦁
|
|
🦁
|
Multiple sclerosis in the north Cambridgeshire districts of East Anglia.
N. Robertson,
J. Deans,
M. Fraser,
D. Compston
|
5 |
1995 |
5
🦁
|
|
🦁
|
Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.
N. Robertson,
J. Deans,
M. Fraser,
D. Compston
|
5 |
1996 |
5
🦁
|
|
🐢
|
Patterns of disease in concordant parent–child pairs with multiple sclerosis
R. Hupperts,
S. Broadley,
A. Mander,
D. Clayton,
D. Compston,
N. Robertson
|
5 |
2001 |
5
🐢
|
|
🐜
|
Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region
7 auth.
N. Wood,
S. Sawcer,
H. Kellar-Wood,
P. Holmans,
D. Clayton,
N. Robertson,
...
D. Compston
|
3 |
1995 |
3
🐜
|
|
🦁
|
Moyamoya disease presenting as Valsalva related partial seizures
N. Robertson,
D. Compston,
P. Kirkpatrick
|
3 |
1999 |
3
🦁
|
|
🐢
|
The association between Anti‐EBNA‐1 IgG and multiple sclerosis clinical disease activity – response
G. Ingram,
N. Robertson
|
3 |
2010 |
3
🐢
|
